J&J last month told some hospitals it would require them to pay full price for two drugs, the blood thinner Xarelto and gut-disorder treatment Stelara, and then apply later for rebates.

J&J says the majority of claimants support its settlement offer. But it has paused a vote count for a short time so that it can gather additional votes from plaintiffs who have until recently ...

Two litigation shareholders are leaving GrayRobinson and taking eight other attorneys with them to form a spinoff boutique with offices in Orlando and Tallahassee. GrayRobinson is losing 10 ...

J&J had proposed the strategy last month, which it said would help cut down on the drug subsidy program's alleged widespread misuse. The company said it would kick off the policy on Oct. 15 for ...

Johnson & Johnson told certain hospitals in the U.S. in a notice on Friday that they will have to pay full price for two drugs – Stelara and Xarelto – that the drugmaker has been selling at a ...

A spokesperson for HRSA, which oversees the 340B program, told the publication that J&J's rebate plan does not align with the 340B law and has not been approved by federal officials. An HRSA ...

J&J acquired the FcRn blocker in its takeover of Momenta Pharmaceuticals in 2020. The drugmaker sees nipocalimab as a candidate that can generate peak sales in excess of $5 billion, despite argenx ...

Dr. Craig West is the founder of Capitaliz and has been working with business owners on succession and exit strategies for over 20 years. Succession and exit planning are crucial for business ...

Truly unexpected news considering they spent the entire summer estranged and J.Lo filed for divorce on August 20. Sooooo...are they back together? Here's what we know: According to People ...

Former GrayRobinson shareholders Mayanne Downs and Jeffrey Aaron have left the firm and taken eight other attorneys with them to start a spinoff boutique firm in Orlando. "Mayanne Downs and Jeff ...